What is the clinical evidence from this study?

Population: Atrial fibrillation. Intervention: I(KACh) deficiency (knockout model) vs. Wild-type mice. Primary outcome: Induction of atrial fibrillation in the presence of carbachol.

What does this research mean for the field?

Activation of the I(KACh) channel is crucial for the generation of vagally mediated atrial fibrillation, as evidenced by the inability to induce atrial fibrillation in I(KACh)-deficient knockout mice. Novelty: ClaimNovelty.NOVEL_FINDING. Consensus alignment: ConsensusAlignment.NEUTRAL.

What question did this study set out to answer?

This research aims to explore the role of I(KACh) in atrial fibrillation and the effects of its blockade.

June 24, 2026Journal of the American College of Cardiology

Evaluation of the role of IKAChin atrial fibrillation using a mouse knockout model

View Full Paper

Ask AI

Bookmark

Key result

I(KACh) knockout completely prevents carbachol-induced AF in mice versus ~71% in wild-type.

Why the study?

Vagal stimulation predisposes to AF, but the specific role of I(KACh) in AF generation and the electrophysiologic effects of specific I(KACh) blockade have not been studied.

Does I(KACh) deficiency prevent carbachol-induced atrial fibrillation in a mouse model?

Key Points

This research aims to explore the role of I(KACh) in atrial fibrillation and the effects of its blockade.
Conducted experiments on adult wild-type and I(KACh)-deficient knockout mice.
Compared electrophysiologic features of KO and WT mice with and without carbachol administration.
Assessed the induction of atrial and ventricular arrhythmias in both mouse types.
Atrial fibrillation was induced in 10 out of 14 WT mice with carbachol, lasting an average of 5.7 minutes.
No atrial fibrillation was observed in KO mice.
KO mice showed shorter sinus node recovery times and greater ventricular effective refractory periods compared to WT mice.

Structured PICO

Does I(KACh) deficiency prevent carbachol-induced atrial fibrillation in a mouse model?

Population

Adult wild-type and I(KACh)-deficient knockout mice studied to assess the role of I(KACh) in atrial fibrillation.

Exposure

I(KACh) gene knockout (deficiency) evaluated in the presence and absence of muscarinic receptor agonist carbachol

Comparator

Wild-type (WT) mice

Outcome

Induction of atrial fibrillationsurrogate

Main Result

Absolute Event Rate: 0% vs 71.4%

Lack of I(KACh) prevented carbachol-induced atrial fibrillation in mice, suggesting specific I(KACh) blockers might be useful for treating AF without adverse ventricular or AV node effects.

Discussion

No takes yet. Share an insight, caveat, or question.

Implication

IKACh blockade suppresses AF in mice; leaves open translation to human therapy.

Cite This Study

Kovoor et al. (2001) studied Atrial fibrillation. I(KACh) deficiency (knockout model) vs. Wild-type mice was evaluated on Induction of atrial fibrillation in the presence of carbachol. Atrial fibrillation was induced by carbachol in 10 of 14 wild-type mice (71.4%) but could not be induced in I(KACh)-deficient knockout mice.

synapsesocial.com/papers/6a3b4caa9889cf2b930e5c50 https://doi.org/10.1016/s0735-1097(01)01304-3

Topics

Atrial fibrillation Persistent AF management Anticoagulation in AF

View Full Paper

Ask AI

Bookmark

Evaluation of the role of IKAChin atrial fibrillation using a mouse knockout model

Key Points

Structured PICO

Main Result

Discussion

Implication

Cite This Study

Topics

Evaluation of the role of IKAChin atrial fibrillation using a mouse knockout model

Key Points

Structured PICO

Main Result

Discussion

Implication

Cite This Study

Also Consider

Topics

Also Consider